A “Thank You Gift” From Pres. Trump - Genius

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

AKRO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.94%

Insider Buying (Last 12 Months): $2,828,000.00

Insider Selling (Last 12 Months): $22,728,155.84

Akero Therapeutics Insider Trading History Chart

Akero Therapeutics Share Price & Price History

^$32.73

▲ +1.53 (4.90%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

Ever heard of this 8-day bitcoin profit window?

From DTI | Ad

Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.

It’s coming up quick.

Akero Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/15/2024	Catriona Yale	Insider	Sell	9,061	$27.73	$251,261.53	74,158
11/1/2024	Andrew Cheng	CEO	Sell	108,366	$31.73	$3,438,453.18	605,417
11/1/2024	Catriona Yale	Insider	Sell	15,485	$32.62	$505,120.70	74,158
11/1/2024	Jonathan Young	COO	Sell	50,716	$31.57	$1,601,104.12	216,286
10/30/2024	Catriona Yale	Insider	Sell	4,515	$32.53	$146,872.95	74,158
10/18/2024	Andrew Cheng	CEO	Sell	63,539	$31.53	$2,003,384.67	605,417
10/16/2024	Andrew Cheng	CEO	Sell	24,992	$31.14	$778,250.88	605,417
10/14/2024	Catriona Yale	Insider	Sell	6,136	$30.03	$184,264.08	74,158
10/14/2024	Jonathan Young	COO	Sell	40,000	$30.15	$1,206,000.00	226,286
10/1/2024	Jonathan Young	COO	Sell	10,000	$28.18	$281,800.00	226,286
9/20/2024	Catriona Yale	Insider	Sell	5,500	$27.65	$152,075.00	75,294
9/18/2024	Catriona Yale	Insider	Sell	3,871	$27.56	$106,684.76	75,294
9/16/2024	Catriona Yale	Insider	Sell	2,485	$27.52	$68,387.20	75,294
9/10/2024	Andrew Cheng	CEO	Sell	1,738	$26.18	$45,500.84	605,417
9/10/2024	Catriona Yale	Insider	Sell	637	$26.18	$16,676.66	75,294
9/10/2024	Jonathan Young	COO	Sell	568	$26.18	$14,870.24	236,286
9/10/2024	William Richard White	CFO	Sell	639	$26.18	$16,729.02	41,152
8/26/2024	Catriona Yale	Insider	Sell	5,200	$27.51	$143,052.00	75,931
8/26/2024	William Richard White	CFO	Sell	75,159	$27.21	$2,045,076.39	41,791
8/23/2024	Catriona Yale	Insider	Sell	8,851	$27.53	$243,668.03	75,931
8/1/2024	Jonathan Young	COO	Sell	5,000	$26.75	$133,750.00	241,854
7/24/2024	William Richard White	CFO	Sell	139,083	$26.98	$3,752,459.34	41,791
7/16/2024	William Richard White	CFO	Sell	34,811	$28.04	$976,100.44	41,791
7/1/2024	Jonathan Young	COO	Sell	5,000	$23.40	$117,000.00	246,854
6/11/2024	Andrew Cheng	CEO	Sell	7,894	$22.64	$178,720.16	581,553
6/11/2024	Catriona Yale	Insider	Sell	2,825	$22.64	$63,958.00	74,867
6/11/2024	Jonathan Young	COO	Sell	2,516	$22.64	$56,962.24	250,790
6/11/2024	Patrick Lamy	VP	Sell	569	$22.64	$12,882.16	18,562
6/11/2024	William Richard White	CFO	Sell	2,831	$22.64	$64,093.84	46,799
6/3/2024	Jonathan Young	COO	Sell	5,000	$19.29	$96,450.00	253,306
5/1/2024	Jonathan Young	COO	Sell	5,000	$20.15	$100,750.00	258,306
4/1/2024	Jonathan Young	COO	Sell	5,000	$24.38	$121,900.00	263,306
3/4/2024	Andrew Cheng	CEO	Sell	75,000	$32.87	$2,465,250.00	591,416
3/4/2024	Catriona Yale	Insider	Sell	20,646	$35.49	$732,726.54	78,415
12/27/2023	Jonathan Young	COO	Sell	5,414	$24.00	$129,936.00	185,131
12/14/2023	Andrew Cheng	CEO	Sell	1,628	$20.76	$33,797.28	550,911
12/14/2023	Catriona Yale	Insider	Sell	597	$20.76	$12,393.72	77,910
12/14/2023	Jonathan Young	COO	Sell	543	$20.76	$11,272.68	185,131
12/14/2023	William Richard White	CFO	Sell	611	$20.76	$12,684.36	50,354
12/11/2023	Andrew Cheng	CEO	Sell	7,405	$20.02	$148,248.10	552,539
12/8/2023	Andrew Cheng	CEO	Sell	12,873	$20.01	$257,588.73	460,998
12/8/2023	G. Walmsley Graham	Director	Buy	100,000	$19.83	$1,983,000.00	800,000
11/30/2023	G. Walmsley Graham	Director	Buy	50,000	$16.90	$845,000.00	650,000
11/17/2023	Jonathan Young	COO	Sell	30,000	$14.68	$440,400.00	153,177
10/2/2023	Andrew Cheng	CEO	Sell	25,000	$47.91	$1,197,750.00	460,998
10/2/2023	Jonathan Young	COO	Sell	490	$51.10	$25,039.00	183,177
9/21/2023	Catriona Yale	Insider	Sell	5,000	$48.07	$240,350.00	46,010
9/13/2023	Andrew Cheng	CEO	Sell	1,682	$50.34	$84,671.88	460,998
9/13/2023	Catriona Yale	Insider	Sell	617	$50.34	$31,059.78	46,010
9/13/2023	Jonathan Young	COO	Sell	562	$50.34	$28,291.08	183,177
9/13/2023	William Richard White	CFO	Sell	632	$50.34	$31,814.88	18,468
9/1/2023	Andrew Cheng	CEO	Sell	25,000	$49.77	$1,244,250.00	462,680
8/28/2023	Catriona Yale	Insider	Sell	5,745	$49.99	$287,192.55	46,627
8/8/2023	G. Walmsley Graham	Director	Buy	25,000	$42.06	$1,051,500.00	600,000
8/1/2023	G. Walmsley Graham	Director	Buy	25,000	$43.26	$1,081,500.00	575,000
7/28/2023	G. Walmsley Graham	Director	Buy	30,000	$42.69	$1,280,700.00	550,000
7/3/2023	Andrew Cheng	CEO	Sell	25,000	$44.88	$1,122,000.00	447,680
6/23/2023	Catriona Yale	Insider	Sell	11,000	$50.76	$558,360.00	46,627
6/21/2023	Catriona Yale	Insider	Sell	11,349	$52.26	$593,098.74	68,627
6/20/2023	William Richard White	CFO	Sell	20,777	$55.00	$1,142,735.00	19,100
6/16/2023	Timothy Rolph	Insider	Sell	78,200	$54.78	$4,283,796.00	151,220
6/16/2023	Tomas J. Heyman	Director	Sell	26,000	$54.67	$1,421,420.00
6/13/2023	Andrew Cheng	CEO	Sell	1,613	$55.16	$88,973.08	407,680
6/13/2023	Jonathan Young	COO	Sell	538	$55.16	$29,676.08	183,739
6/13/2023	Timothy Rolph	Insider	Sell	509	$55.16	$28,076.44	189,420
6/13/2023	William Richard White	CFO	Sell	606	$55.16	$33,426.96	22,377
6/1/2023	Andrew Cheng	CEO	Sell	25,000	$45.10	$1,127,500.00	409,293
5/19/2023	G. Walmsley Graham	Director	Buy	120,000	$42.00	$5,040,000.00	520,000
5/1/2023	Andrew Cheng	CEO	Sell	25,000	$45.07	$1,126,750.00	409,293
4/3/2023	Andrew Cheng	CEO	Sell	25,000	$37.94	$948,500.00	369,293
3/1/2023	Andrew Cheng	CEO	Sell	25,000	$46.65	$1,166,250.00	370,999
2/1/2023	Andrew Cheng	CEO	Sell	25,000	$49.06	$1,226,500.00	370,999
1/13/2023	Catriona Yale	Insider	Sell	5,000	$50.53	$252,650.00	81,268
1/3/2023	Andrew Cheng	CEO	Sell	25,000	$51.27	$1,281,750.00	370,999
1/3/2023	Jonathan Young	COO	Sell	8,777	$54.64	$479,575.28	184,911
12/28/2022	Timothy Rolph	Insider	Sell	1,700	$50.00	$85,000.00	203,032
12/28/2022	William Richard White	CFO	Sell	999	$49.76	$49,710.24	23,624
12/27/2022	Jonathan Young	COO	Sell	12,500	$49.57	$619,625.00	182,449
12/12/2022	Catriona Yale	Insider	Sell	5,000	$43.23	$216,150.00	86,268
12/1/2022	Andrew Cheng	CEO	Sell	10,000	$46.07	$460,700.00	310,148
12/1/2022	Skorpios Trust	Major Shareholder	Sell	1,636,000	$43.50	$71,166,000.00	3,271,829
11/30/2022	Seth Loring Harrison	Director	Sell	11,101	$46.94	$521,080.94	136,301
11/15/2022	Timothy Rolph	Insider	Sell	3,138	$45.04	$141,335.52	187,784
11/10/2022	Catriona Yale	Insider	Sell	5,000	$39.42	$197,100.00	72,073
11/1/2022	Andrew Cheng	CEO	Sell	10,000	$43.42	$434,200.00	310,148
10/27/2022	Seth Loring Harrison	Director	Sell	66,426	$41.53	$2,758,671.78	168,540
10/25/2022	Jonathan Young	COO	Sell	12,500	$44.72	$559,000.00	163,254
10/25/2022	Seth Loring Harrison	Director	Sell	4,515	$44.92	$202,813.80	300,851
10/25/2022	Timothy Rolph	Insider	Sell	10,653	$45.09	$480,343.77	195,684
10/13/2022	William Richard White	CFO	Sell	20,000	$39.82	$796,400.00	4,429
10/10/2022	Catriona Yale	Insider	Sell	5,000	$37.99	$189,950.00	77,073
10/6/2022	Timothy Rolph	Insider	Sell	22,500	$39.29	$884,025.00	186,337
10/3/2022	Andrew Cheng	CEO	Sell	10,000	$33.23	$332,300.00	310,148
9/30/2022	Timothy Rolph	Insider	Sell	45,000	$32.72	$1,472,400.00	198,837
9/13/2022	Andrew Cheng	CEO	Sell	60,000	$27.42	$1,645,200.00	310,148
9/13/2022	Catriona Yale	Insider	Sell	40,000	$27.48	$1,099,200.00	82,073
9/13/2022	William Richard White	CFO	Sell	32,500	$27.03	$878,475.00	4,429
3/1/2022	Andrew Cheng	CEO	Sell	10,000	$17.59	$175,900.00
2/1/2022	Andrew Cheng	CEO	Sell	10,000	$17.56	$175,600.00
1/14/2022	William Richard White	CFO	Sell	9,700	$22.03	$213,691.00
1/10/2022	Andrew Cheng	CEO	Sell	10,000	$19.55	$195,500.00
12/21/2021	William Richard White	CFO	Sell	100	$22.00	$2,200.00
12/17/2021	William Richard White	CFO	Sell	3,200	$22.04	$70,528.00

Ever heard of this 8-day bitcoin profit window?

From DTI | Ad

It’s coming up quick.

SEC Filings (Institutional Ownership Changes) for Akero Therapeutics (NASDAQ:AKRO)

Institutional Buying and Selling by Quarter

Akero Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	1,571,012	$45.08M	0.0%	-3.0%	2.251%
11/15/2024	Barclays PLC	127,668	$3.66M	0.0%	+127.9%	0.183%
11/15/2024	Y Intercept Hong Kong Ltd	16,916	$0.49M	0.0%	+13.8%	0.024%
11/15/2024	XTX Topco Ltd	10,740	$0.31M	0.0%	N/A	0.015%
11/15/2024	Wellington Management Group LLP	7,896,632	$226.55M	0.0%	+54.4%	11.313%
11/15/2024	State Street Corp	2,502,946	$71.81M	0.0%	-6.9%	3.586%
11/15/2024	RTW Investments LP	5,919,435	$169.83M	2.5%	+9.0%	8.481%
11/15/2024	Redmile Group LLC	1,387,479	$39.81M	2.3%	-14.1%	1.988%
11/15/2024	Point72 Asset Management L.P.	1,303,323	$37.39M	0.1%	N/A	1.867%
11/15/2024	Janus Henderson Group PLC	7,077,478	$203.05M	0.1%	+2.9%	10.140%
11/15/2024	Cinctive Capital Management LP	65,307	$1.87M	0.1%	N/A	0.094%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	9,230	$0.27M	0.0%	N/A	0.013%
11/15/2024	Erste Asset Management GmbH	47,000	$1.33M	0.0%	N/A	0.067%
11/14/2024	Fred Alger Management LLC	269,601	$7.74M	0.0%	+117.8%	0.386%
11/14/2024	Alkeon Capital Management LLC	3,325,004	$95.39M	0.2%	-0.1%	4.764%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	60,416	$1.73M	0.0%	-7.9%	0.087%
11/13/2024	BNP Paribas Financial Markets	20,702	$0.59M	0.0%	-28.8%	0.030%
11/13/2024	Propel Bio Management LLC	343,729	$9.86M	5.7%	+4.9%	0.492%
11/13/2024	FMR LLC	30,337	$0.87M	0.0%	+732.1%	0.043%
11/13/2024	Summit Financial Wealth Advisors LLC	7,155	$0.21M	0.0%	N/A	0.010%
11/13/2024	The Manufacturers Life Insurance Company	96,549	$2.77M	0.0%	-9.9%	0.138%
11/12/2024	Algert Global LLC	68,052	$1.95M	0.1%	+8.3%	0.098%
11/12/2024	Charles Schwab Investment Management Inc.	532,596	$15.28M	0.0%	-4.0%	0.767%
11/9/2024	Intech Investment Management LLC	17,107	$0.49M	0.0%	N/A	0.025%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	10,159	$0.29M	0.0%	-85.5%	0.015%
11/7/2024	LMR Partners LLP	20,597	$0.59M	0.0%	+17.0%	0.030%
11/6/2024	Simplify Asset Management Inc.	283,766	$8.14M	0.4%	+15.6%	0.409%
11/5/2024	Victory Capital Management Inc.	7,370	$0.21M	0.0%	N/A	0.011%
10/29/2024	Emerald Advisers LLC	524,427	$15.05M	0.6%	+1.8%	0.758%
10/29/2024	Emerald Mutual Fund Advisers Trust	415,201	$11.91M	0.6%	-2.3%	0.600%
10/25/2024	China Universal Asset Management Co. Ltd.	13,354	$0.38M	0.0%	+64.4%	0.019%
10/25/2024	abrdn plc	123,358	$3.54M	0.0%	-38.1%	0.178%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,511	$71K	0.0%	+21.6%	0.004%
10/22/2024	Eastern Bank	3,500	$100K	0.0%	N/A	0.005%
10/16/2024	Rheos Capital Works Inc.	276,000	$7.92M	0.4%	+27.8%	0.399%
10/11/2024	Creative Planning	12,937	$0.37M	0.0%	N/A	0.019%
10/5/2024	Handelsbanken Fonder AB	20,000	$0.57M	0.0%	+12.4%	0.029%
8/16/2024	Perceptive Advisors LLC	1,499,897	$35.19M	0.8%	+8.1%	2.169%
8/16/2024	Quarry LP	2,000	$47K	0.0%	-32.2%	0.003%
8/16/2024	Algert Global LLC	62,861	$1.48M	0.0%	-28.1%	0.091%
8/15/2024	Long Focus Capital Management LLC	719,604	$16.88M	0.6%	+119.0%	1.041%
8/15/2024	The Manufacturers Life Insurance Company	107,172	$2.51M	0.0%	+26.1%	0.155%
8/15/2024	Millennium Management LLC	169,591	$3.98M	0.0%	-78.0%	0.245%
8/15/2024	Deerfield Management Company L.P. Series C	11,867	$0.28M	0.0%	-13.0%	0.017%
8/14/2024	Fred Alger Management LLC	123,788	$2.90M	0.0%	-90.7%	0.179%
8/14/2024	ProShare Advisors LLC	12,511	$0.29M	0.0%	-16.6%	0.018%
8/14/2024	Profund Advisors LLC	22,838	$0.54M	0.0%	-50.2%	0.033%
8/13/2024	Ensign Peak Advisors Inc	237,494	$5.57M	0.0%	+2.1%	0.343%
8/9/2024	Renaissance Technologies LLC	24,100	$0.57M	0.0%	N/A	0.035%
8/9/2024	Dimensional Fund Advisors LP	18,162	$0.43M	0.0%	-60.0%	0.026%
8/8/2024	American Century Companies Inc.	14,811	$0.35M	0.0%	N/A	0.021%
8/7/2024	Headlands Technologies LLC	17,003	$0.40M	0.0%	+303.2%	0.025%
8/6/2024	Quest Partners LLC	12,609	$0.30M	0.0%	+22,021.1%	0.018%
8/6/2024	Emerald Advisers LLC	515,252	$12.09M	0.5%	-4.4%	0.745%
8/3/2024	TD Asset Management Inc	154,592	$3.63M	0.0%	+23.7%	0.224%
8/1/2024	Rhumbline Advisers	107,338	$2.52M	0.0%	+30.3%	0.155%
7/29/2024	Principal Financial Group Inc.	9,494	$0.22M	0.0%	-31.0%	0.014%
7/26/2024	Bank of New York Mellon Corp	251,234	$5.89M	0.0%	+32.8%	0.363%
7/12/2024	SG Americas Securities LLC	14,517	$0.34M	0.0%	+191.2%	0.021%
7/11/2024	Bourgeon Capital Management LLC	8,700	$0.20M	0.0%	-42.6%	0.013%
6/4/2024	DekaBank Deutsche Girozentrale	20,000	$0.49M	0.0%	-27.5%	0.029%
5/28/2024	Teachers Retirement System of The State of Kentucky	28,521	$0.72M	0.0%	+30.0%	0.041%
5/20/2024	Virtu Financial LLC	10,692	$0.27M	0.0%	N/A	0.015%
5/16/2024	California State Teachers Retirement System	54,185	$1.37M	0.0%	+12.7%	0.078%
5/16/2024	Janus Henderson Group PLC	6,121,970	$154.59M	0.1%	+42.2%	8.853%
5/16/2024	Redmile Group LLC	1,858,702	$46.95M	1.7%	+67.5%	2.688%
5/15/2024	Baker BROS. Advisors LP	2,713,205	$68.54M	0.9%	+14.6%	3.924%
5/15/2024	Yiheng Capital Management L.P.	1,434,179	$36.23M	2.0%	-25.4%	2.074%
5/15/2024	Price T Rowe Associates Inc. MD	4,060,479	$102.57M	0.0%	+10.5%	5.872%
5/14/2024	Propel Bio Management LLC	327,752	$8.28M	4.6%	+227.6%	0.474%
5/14/2024	American International Group Inc.	30,326	$0.77M	0.0%	+18.9%	0.044%
5/13/2024	Seven Eight Capital LP	40,384	$1.02M	0.1%	-35.3%	0.058%
5/13/2024	Ameritas Investment Partners Inc.	6,175	$0.16M	0.0%	+20.0%	0.009%
5/10/2024	Vanguard Group Inc.	3,669,923	$92.70M	0.0%	+19.0%	5.307%
5/9/2024	State Board of Administration of Florida Retirement System	9,460	$0.24M	0.0%	-35.4%	0.014%
5/8/2024	Entropy Technologies LP	52,775	$1.33M	0.1%	+17.7%	0.076%
5/8/2024	ProShare Advisors LLC	15,001	$0.38M	0.0%	+24.4%	0.022%
5/8/2024	Russell Investments Group Ltd.	1,233	$31K	0.0%	+2,366.0%	0.002%
5/8/2024	Headlands Technologies LLC	4,217	$0.11M	0.0%	+253.5%	0.006%
5/7/2024	Swiss National Bank	105,000	$2.65M	0.0%	+19.9%	0.152%
5/7/2024	SG Americas Securities LLC	4,985	$0.13M	0.0%	-33.4%	0.007%
5/1/2024	Capstone Investment Advisors LLC	87,292	$2.21M	0.0%	N/A	0.126%
5/1/2024	BNP Paribas Financial Markets	59,294	$1.50M	0.0%	-72.1%	0.086%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	25,658	$0.65M	0.0%	-35.7%	0.037%
4/29/2024	Principal Financial Group Inc.	13,766	$0.35M	0.0%	+15.6%	0.020%
4/29/2024	China Universal Asset Management Co. Ltd.	10,800	$0.27M	0.0%	+67.5%	0.016%
4/23/2024	Global Retirement Partners LLC	5,747	$0.15M	0.0%	+54.5%	0.008%
4/19/2024	Bourgeon Capital Management LLC	15,150	$0.38M	0.1%	N/A	0.022%
4/18/2024	Quattro Financial Advisors LLC	10,000	$0.25M	0.1%	+43,378.3%	0.018%
4/5/2024	Los Angeles Capital Management LLC	8,343	$0.21M	0.0%	N/A	0.015%
3/5/2024	Wellington Management Group LLP	2,881,989	$67.29M	0.0%	+247.7%	5.119%
2/26/2024	Perceptive Advisors LLC	967,775	$22.60M	0.5%	-60.0%	1.737%
2/20/2024	Quarry LP	1,750	$41K	0.0%	+40.0%	0.003%
2/14/2024	ADAR1 Capital Management LLC	16,000	$0.37M	0.1%	N/A	0.029%
2/14/2024	Avidity Partners Management LP	235,000	$5.49M	0.2%	-68.2%	0.422%
2/14/2024	Seven Eight Capital LP	62,464	$1.46M	0.2%	N/A	0.112%
2/14/2024	RTW Investments LP	3,592,759	$83.89M	1.3%	N/A	6.450%
2/13/2024	University of Wisconsin Foundation	372,575	$8.70M	14.5%	+258.9%	0.669%
2/13/2024	Tower Research Capital LLC TRC	3,944	$92K	0.0%	+277.1%	0.007%
2/13/2024	Rafferty Asset Management LLC	451,832	$10.55M	0.0%	+146.2%	0.811%

Data available starting January 2016

Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Today's Range

Now: $32.73

$31.05

$32.95

50 Day Range

MA: $29.95

$26.64

$35.28

52 Week Range

Now: $32.73

$15.32

$37.00

Volume

824,695 shs

Average Volume

692,323 shs

Market Capitalization

$2.28 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Akero Therapeutics?: Akero Therapeutics' top insider shareholders include:
Skorpios Trust (Major Shareholder)
G Walmsley Graham (Director)
Andrew Cheng (CEO)
Jonathan Young (COO)
Timothy Rolph (Insider)
Seth Loring Harrison (Director)
Catriona Yale (Insider)
William Richard White (CFO)
Patrick Lamy (VP)
Tomas J Heyman (Director)
Learn More about top insider investors at Akero Therapeutics.
Who are the major institutional investors of Akero Therapeutics?: Akero Therapeutics' top institutional investors include:
Wellington Management Group LLP — 11.31%
Janus Henderson Group PLC — 10.14%
RTW Investments LP — 8.48%
Alkeon Capital Management LLC — 4.76%
State Street Corp — 3.59%
Geode Capital Management LLC — 2.25%
Learn More about top institutional investors of Akero Therapeutics stock.
Which institutional investors are selling Akero Therapeutics stock?: In the last quarter, AKRO stock was sold by these institutional investors:
Redmile Group LLC
State Street Corp
abrdn plc
Connor Clark & Lunn Investment Management Ltd.
Geode Capital Management LLC
Charles Schwab Investment Management Inc.
The Manufacturers Life Insurance Company
Emerald Mutual Fund Advisers Trust
In the previous year, company insiders that have sold Akero Therapeutics company stock include:
Skorpios Trust (Major Shareholder)
G Walmsley Graham (Director)
Andrew Cheng (CEO)
Jonathan Young (COO)
Timothy Rolph (Insider)
Learn More investors selling Akero Therapeutics stock.
Which institutional investors are buying Akero Therapeutics stock?: During the last quarter, AKRO stock was purchased by institutional investors including:
Wellington Management Group LLP
Point72 Asset Management L.P.
RTW Investments LP
Janus Henderson Group PLC
Ikarian Capital LLC
Fred Alger Management LLC
Barclays PLC
Cinctive Capital Management LP